Clinical Trial Update: First Time in Human (FTIH) Safety and Pharmacokinetics (PK) Study of GSK3036656 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 first-time-in-human safety and PK study of GSK3036656 in healthy subjects completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• GSK3036656

Snippet

Sponsor: GlaxoSmithKline | Conditions: Tuberculosis | Phase 1 | Status: COMPLETED | Results posted: 2019-04-19